BioArts International (BioArts), today announced that it will sell five
dog cloning service slots to the general public via a worldwide, online
auction to be held June 18th. "We are thrilled to announce the Best
Friends Again program," said CEO Lou
Hawthorne. "This auction will give five very
lucky people the ability to clone their family dogs. Given how
challenging it is to clone dogs, this is a very rare and special offer." The Best Friends Again website, www.bestfriendsagain.com
showcases three perfect clones of Hawthorne´s
beloved family dog "Missy"
who died in 2002. Missy has been the subject of extensive cloning
research since the "Missyplicity Project" began in 1997. "I can´t
decide which is more exciting: finally having three clones of Missy or
being able to offer this amazing service to others," said Hawthorne. BioArts has been granted the sole, worldwide license for the cloning of
dogs, cats and endangered species. The license was granted by Start
Licensing, Inc. and applies to the somatic cell nuclear transfer (SCNT)
cloning patents developed at the Roslin Institute for the cloning of
Dolly the sheep. BioArts International is a new biotech startup focused on unique
untapped markets in the global companion animal, premium livestock and
human genomics industries. The Best Friends Again program is a
partnership between BioArts and the Sooam Biotech Research Foundation in
South Korea, home to the best and most experienced dog cloning team in
the world. More information about the Best Friends Again program and the
June 18th auction is available at www.bestfriendsagain.com.
More information about BioArts is available at www.bioarts.com.
